Immunohistologically, the coexpression of CD5 and CD23 on the clonal population of B cells, detected by flow cytometry, can be sued for the diagnosis of most CLL cases [6, 7]. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.